James Investment Research Inc Petmed Express Inc Transaction History

James Investment Research Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$17.16 - $22.14 $231,076 - $298,137	-13,466 Reduced 44.62%	16,712 $296,000
Q2 2022 Aug 01, 2022	BUY	$19.9 - $26.13 $137,688 - $180,793	6,919 Added 29.75%	30,178 $601,000
Q1 2022 Apr 22, 2022	BUY	$23.62 - $29.18 $178,543 - $220,571	7,559 Added 48.15%	23,259 $600,000
Q4 2021 Jan 28, 2022	BUY	$25.26 - $32.0 $143,982 - $182,400	5,700 Added 57.0%	15,700 $397,000
Q3 2021 Oct 22, 2021	SELL	$26.5 - $34.0 $108,650 - $139,400	-4,100 Reduced 29.08%	10,000 $269,000
Q2 2021 Jul 26, 2021	BUY	$27.73 - $46.06 $108,147 - $179,634	3,900 Added 38.24%	14,100 $449,000
Q1 2021 Apr 22, 2021	SELL	$29.77 - $51.8 $305,142 - $530,950	-10,250 Reduced 50.12%	10,200 $358,000
Q4 2020 Jan 27, 2021	BUY	$28.96 - $33.77 $592,232 - $690,596	20,450 New	20,450 $656,000

102

9.52M

39.6K

137K

Ticker PETS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 21,013,800
Market Cap $102M
Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.